Clearside Biomedical, Inc. ( CLSD) - Key Metrics
Stock symbol CLSD is outdated, potentially delisted? Maybe it is available on other exchange?
CLSD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.09 | -$0.87 | -$0.91 | -$0.91 |
| 2025Q1 | $0.45 | -$1.60 | -$1.14 | -$1.14 |
| 2024Q4 | $0.06 | -$1.44 | -$1.04 | -$1.13 |
| 2024Q3 | $0.21 | -$1.54 | -$1.19 | -$1.20 |
| 2024Q2 | $0.02 | -$1.52 | -$1.14 | -$1.22 |
CLSD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -3.46 |
| 2025Q1 | ? | -2.15 |
| 2024Q4 | ? | -2.47 |
| 2024Q3 | ? | -3.09 |
| 2024Q2 | ? | -3.05 |
CLSD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | -7.59% | ? |
| 2025Q1 | -8.26% | ? |
| 2024Q4 | -7.91% | ? |
| 2024Q3 | -6.28% | ? |
| 2024Q2 | -6.59% | ? |
CLSD
Price: $0.41
52 week price:
Earnings Per Share: -5.11 USD
P/E Ratio: -0.20
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 411200
Ebitda: -18.1 millionMarket Capitalization: 5.2 million